The National Institutes of Health (NIH) is "turbo-charging" with a 5-year,
$2 billion plan to speed biological discoveries into blockbuster treatments.
Designed to leverage leaps in biotechnology, the ambitious strategy aims to
reveal the most fundamental workings of the body by encouraging and rewarding
high-risk research. A vast network of community physicians is then envisioned
to quickly test emerging therapies.
"Some say these initiatives are bold, maybe too bold," said Francis
Collins, MD, PhD, director of the National Human Genome Research Institute.
"Fifteen years ago they said the same thing about the Human Genome Project."
Vastag B. NIH: Plan to Speed Biomedical Payoffs. JAMA. 2003;290(16):2115-2116. doi:10.1001/jama.290.16.2115